Viewing Study NCT05642468


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-04 @ 4:00 PM
Study NCT ID: NCT05642468
Status: COMPLETED
Last Update Posted: 2025-07-30
First Post: 2022-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Sponsor: Albireo, an Ipsen Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module